UNLABELLED: A 13-year-old Japanese boy with pituitary prolactinoma whose growth had been retarded for more than 2 years was treated with bromocriptine alone for 140 weeks. After treatment, the serum level of prolactin, which was 1200 ng/ml before treatment, returned to normal and the pituitary tumour seen on the initial brain MRI had rapidly decreased in size after 16 weeks of treatment. Thereafter, his height improved (from -2.1 to -1.7 SDS). CONCLUSION: the favourable response obtained in this patient implies that bromocriptine monotherapy can be an effective first-line treatment for children with prolactinoma. Copyright 2004 Springer-Verlag
UNLABELLED: A 13-year-old Japanese boy with pituitary prolactinoma whose growth had been retarded for more than 2 years was treated with bromocriptine alone for 140 weeks. After treatment, the serum level of prolactin, which was 1200 ng/ml before treatment, returned to normal and the pituitary tumour seen on the initial brain MRI had rapidly decreased in size after 16 weeks of treatment. Thereafter, his height improved (from -2.1 to -1.7 SDS). CONCLUSION: the favourable response obtained in this patient implies that bromocriptine monotherapy can be an effective first-line treatment for children with prolactinoma. Copyright 2004 Springer-Verlag
Authors: A Colao; S Loche; M Cappa; A Di Sarno; M L Landi; F Sarnacchiaro; G Facciolli; G Lombardi Journal: J Clin Endocrinol Metab Date: 1998-08 Impact factor: 5.958
Authors: L A Kane; M C Leinung; B W Scheithauer; E J Bergstralh; E R Laws; R V Groover; K Kovacs; E Horvath; D Zimmerman Journal: J Clin Endocrinol Metab Date: 1994-10 Impact factor: 5.958